HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CCT245737

a CHK1 inhibitor; structure in first source
Also Known As:
5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Aherne, G Wynne: 1 article (01/2016)
2. Box, Gary: 1 article (01/2016)
3. Boxall, Kathy J: 1 article (01/2016)
4. Collins, Ian: 1 article (01/2016)
5. De Haven Brandon, Alexis K: 1 article (01/2016)
6. Eccles, Suzanne A: 1 article (01/2016)
7. Eve, Paul D: 1 article (01/2016)
8. Garrett, Michelle D: 1 article (01/2016)
9. Hayes, Angela: 1 article (01/2016)
10. Henley, Alan T: 1 article (01/2016)

Related Diseases

1. B-Cell Lymphoma (Lymphoma, B Cell)
2. Neoplasms (Cancer)

Related Drugs and Biologics

1. Gemcitabine